Kernicterus and G6PD deficiency - A case series from Oman

Journal of Tropical Pediatrics

Volumn 49, Issue 2, 2003, Pages 74-77

  Kumar Nair, P Arun ^a   Al Khusaiby, Saleh Mohammad ^a  

^a ROYAL HOSPITAL   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MESOPORPHYRIN; PROTOPORPHYRIN TIN;

ARTICLE; CASE STUDY; CHILDBIRTH; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFANT; JAUNDICE; KERNICTERUS; MALE; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RECORD; NEWBORN PERIOD; OMAN; PREVALENCE; TIME;

FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; MALE;

EID: 0037395957     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/49.2.74     Document Type: Article

References (14)

1. Luzzato L, Mata A. Glucose-6-phosphate dehydrogenase deficiency. In: Scriver CR, et al. (eds), The Metabolic Basis of Inherited Disease, 6th edn. McGraw-Hill, New York, 1989; 2237-65.
2. Newman TB, Maisels MJ. Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines. Pediatrics 2000; 105: 242-45.
3. Kaplan, M, Hammernman, C. G6PD deficient neonates: a potential cause for concern in North America. Pediatrics 2000; 106: 1478.
4. Livingstone FB. Data on abnormal hemoglobins and G6PD deficiency in human populations. 2nd edn. University of Michigan, Ann Arbor, 1985.
5. Beutler E, Gaetani G. Kaloustian VD, Luzzatto L, et al. (WHO working group). Glucose-6-phosphate dehydrogenase deficiency. Bull WHO 1989; 67: 601-11.
6. Meloni S, Costa S, et al. Haptoglobin, hemopexin, hemoglobin and hematocrit in erythrocyte glucose-6 phosphate deficient newborn infants. Acta Haematol 1975; 54: 284.
7. Al-Riyami A. Prevalence rate (%) of G6PD deficiency in Oman. National Genetic Blood Disorder Survey. Ministry of Health, Sultanate of Oman, 1998.
8. Center for Disease Control and Prevention (CDC). Kernicterus in full term infants-United States, 1994-1998. MMWR 2001; 50: 491-94.
9. Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 1988; 81: 485-97.
10. Martinez JC, Garcia HO, Otheguy LE, Drummond GS, Kappas A. Control of severe hyperbilirubinemia in full term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics 1999; 103: 1-5.
11. Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in G6PD deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Pediatrics 1998; 101: E1.
12. Kappas A, Drummond GS, Henschke C, Valaes T. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production and phototherapy in controlling hyperbilirubinemia in term and near term newborns. Pediatrics 1995; 95: 468-74.
13. Galbraith RA, Drummond GS, Kappas A. Suppression of bilirubin production in the Criggler-Najjar type 1 syndrome with the heme oxygenase inhibitor tin-mesoporphyrin. Pediatrics 1992; 89: 175-82.
14. Cooke RWI New approach to prevention of kernicterus. Lancet 1999; 353: 1814-15.